156 related articles for article (PubMed ID: 32087093)
1. Non-functioning neuroendocrine pancreatic tumors transforming to malignant insulinomas - four cases and review of the literature.
Juhlin CC; Skoglund S; Juntti-Berggren L; Karlberg M; Calissendorff J
Neuro Endocrinol Lett; 2019 Nov; 40(4):175-183. PubMed ID: 32087093
[TBL] [Abstract][Full Text] [Related]
2. Characteristics, Treatment, Outcomes, and Survival in Neuroendocrine G1 and G2 Pancreatic Tumors: Experiences From a Single Tertiary Referral Center.
Calissendorff J; Bjellerup-Calissendorff F; Bränström R; Juhlin CC; Falhammar H
Front Endocrinol (Lausanne); 2021; 12():657698. PubMed ID: 33927695
[TBL] [Abstract][Full Text] [Related]
3. Transformation of nonfunctioning pancreatic tumor into malignant insulinoma after 3 years: an uncommon clinical course of insulinoma.
Arslan MS; Ozbek M; Karakose M; Tutal E; Ucan B; Yilmazer D; Dilli A; Gultekin SS; Cakal E; Delibasi T
Arch Endocrinol Metab; 2015 Jun; 59(3):270-2. PubMed ID: 26154097
[TBL] [Abstract][Full Text] [Related]
4. Case Report: Giant insulinoma, a very rare tumor causing hypoglycemia.
Tarris G; Rouland A; Guillen K; Loffroy R; Lariotte AC; Rat P; Bouillet B; Andrianiaina H; Petit JM; Martin L
Front Endocrinol (Lausanne); 2023; 14():1125772. PubMed ID: 37234805
[TBL] [Abstract][Full Text] [Related]
5. Significance of chromogranin A and synaptophysin in pancreatic neuroendocrine tumors.
Tomita T
Bosn J Basic Med Sci; 2020 Aug; 20(3):336-346. PubMed ID: 32020844
[TBL] [Abstract][Full Text] [Related]
6. Clinico-pathological features, treatments and survival of malignant insulinomas: a multicenter study.
Veltroni A; Cosaro E; Spada F; Fazio N; Faggiano A; Colao A; Pusceddu S; Zatelli MC; Campana D; Piovesan A; Pia A; Grossrubatscher EM; Filice A; Bianchi A; Razzore P; Toaiari M; Cingarlini S; Landoni L; Micciolo R; Davì MV
Eur J Endocrinol; 2020 Apr; 182(4):439-446. PubMed ID: 32061159
[TBL] [Abstract][Full Text] [Related]
7. Aggressive versus indolent insulinomas: new clinicopathological insights.
Hackeng WM; Brosens LAA; Dreijerink KMA
Endocr Relat Cancer; 2023 May; 30(5):. PubMed ID: 36779771
[TBL] [Abstract][Full Text] [Related]
8. Pasireotide for Refractory Hypoglycemia in Malignant Insulinoma- Case Report and Review of the Literature.
Oziel-Taieb S; Maniry-Quellier J; Chanez B; Poizat F; Ewald J; Niccoli P
Front Endocrinol (Lausanne); 2022; 13():860614. PubMed ID: 35518928
[TBL] [Abstract][Full Text] [Related]
9. Alternative Lengthening of Telomeres and Differential Expression of Endocrine Transcription Factors Distinguish Metastatic and Non-metastatic Insulinomas.
Hackeng WM; Schelhaas W; Morsink FHM; Heidsma CM; van Eeden S; Valk GD; Vriens MR; Heaphy CM; Nieveen van Dijkum EJM; Offerhaus GJA; Dreijerink KMA; Brosens LAA
Endocr Pathol; 2020 Jun; 31(2):108-118. PubMed ID: 32103422
[TBL] [Abstract][Full Text] [Related]
10. A Systematic Review of Proinsulin-Secreting Pancreatic Neuroendocrine Tumors.
Murtha TD; Lupsa BC; Majumdar S; Jain D; Salem RR
J Gastrointest Surg; 2017 Aug; 21(8):1335-1341. PubMed ID: 28510792
[TBL] [Abstract][Full Text] [Related]
11. High VEGF serum values are associated with locoregional spread of gastroenteropancreatic neuroendocrine tumors (GEP-NETs).
Cigrovski Berković M; Čačev T; Catela Ivković T; Marout J; Ulamec M; Zjačić-Rotkvić V; Kapitanović S
Mol Cell Endocrinol; 2016 Apr; 425():61-8. PubMed ID: 26805636
[TBL] [Abstract][Full Text] [Related]
12. Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas.
Tang LH; Untch BR; Reidy DL; O'Reilly E; Dhall D; Jih L; Basturk O; Allen PJ; Klimstra DS
Clin Cancer Res; 2016 Feb; 22(4):1011-7. PubMed ID: 26482044
[TBL] [Abstract][Full Text] [Related]
13. [Differential diagnostic value of the expression of the transcription factor PDX-1 in neuroendocrine and non-neuroendocrine tumors of the pancreas and other organs].
Gurevich LE; Proshchina AE; Voronkova IA; Ashevskaya VE; Korosteleva PA; Dolzhansky OV
Arkh Patol; 2019; 81(5):11-21. PubMed ID: 31626200
[TBL] [Abstract][Full Text] [Related]
14. A personal experience with pancreatic and duodenal neuroendocrine tumors.
Jordan PH
J Am Coll Surg; 1999 Nov; 189(5):470-82. PubMed ID: 10549736
[TBL] [Abstract][Full Text] [Related]
15. A malignant cause of hypoglycaemia: a metastatic insulin-secreting pancreatic neuroendocrine carcinoma.
Sandoval MA; Pagsisihan D; Berberabe A; Palugod-Lopez EG
BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26994053
[TBL] [Abstract][Full Text] [Related]
16. Insulinoma: A retrospective study analyzing the differences between benign and malignant tumors.
Câmara-de-Souza AB; Toyoshima MTK; Giannella ML; Freire DS; Camacho CP; Lourenço DM; Rocha MS; Bacchella T; Jureidini R; Machado MCC; Almeida MQ; Pereira MAA
Pancreatology; 2018 Apr; 18(3):298-303. PubMed ID: 29452754
[TBL] [Abstract][Full Text] [Related]
17. A Practical Approach to the Classification of WHO Grade 3 (G3) Well-differentiated Neuroendocrine Tumor (WD-NET) and Poorly Differentiated Neuroendocrine Carcinoma (PD-NEC) of the Pancreas.
Tang LH; Basturk O; Sue JJ; Klimstra DS
Am J Surg Pathol; 2016 Sep; 40(9):1192-202. PubMed ID: 27259015
[TBL] [Abstract][Full Text] [Related]
18. The functioning side of the pancreas: a review on insulinomas.
Maggio I; Mollica V; Brighi N; Lamberti G; Manuzzi L; Ricci AD; Campana D
J Endocrinol Invest; 2020 Feb; 43(2):139-148. PubMed ID: 31368049
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
Garbrecht N; Anlauf M; Schmitt A; Henopp T; Sipos B; Raffel A; Eisenberger CF; Knoefel WT; Pavel M; Fottner C; Musholt TJ; Rinke A; Arnold R; Berndt U; Plöckinger U; Wiedenmann B; Moch H; Heitz PU; Komminoth P; Perren A; Klöppel G
Endocr Relat Cancer; 2008 Mar; 15(1):229-41. PubMed ID: 18310290
[TBL] [Abstract][Full Text] [Related]
20. Thoracic and duodenopancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1: natural history and function of menin in tumorigenesis.
Pieterman CR; Conemans EB; Dreijerink KM; de Laat JM; Timmers HT; Vriens MR; Valk GD
Endocr Relat Cancer; 2014 Jun; 21(3):R121-42. PubMed ID: 24389729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
